PhRMA Meets With Indian Officials To Discuss Compulsory Licensing
This article was originally published in PharmAsia News
Executive Summary
Executives of the Pharmaceutical Research and Manufacturers of America were in India the last two weeks of October for meetings with member companies. One issue had grabbed their attention: India's move toward compulsory licensing
You may also be interested in...
President Obama May Take Up IP Protection Issue During India Visit
MUMBAI - One of the top priorities for U.S. President Barack Obama during his four day visit to India may be to seek strengthened IP rights protection from the Indian government - a thorny issue that has kept some multinational companies away from committing R&D investments in the country despite availability of a large pool of scientists and significant cost advantages
President Obama May Take Up IP Protection Issue During India Visit
MUMBAI - One of the top priorities for U.S. President Barack Obama during his four day visit to India may be to seek strengthened IP rights protection from the Indian government - a thorny issue that has kept some multinational companies away from committing R&D investments in the country despite availability of a large pool of scientists and significant cost advantages
Stage Set For India To Frame Compulsory Licensing Provisions As Contrasting Groups Make Their Case
MUMBAI - After soliciting views from stakeholders on a "discussion paper" to outline conditions in which a compulsory license could be invoked, India's Department of Industrial Policy and Promotion is now trying to figure out what to do